Is Safety Shot, Inc. overvalued or undervalued?

As of 14 August 2025, the valuation grade for Safety Shot, Inc. has moved from risky to does not qualify, indicating a significant deterioration in its financial standing. The company appears to be overvalued given its negative valuation metrics, including a Price to Book Value of -20.94, an EV to EBIT of -0.79, and an EV to EBITDA of -0.80. These figures suggest that the company is struggling to generate positive earnings and is not a viable investment at its current price.
In comparison to its peers, Safety Shot, Inc. shows a stark contrast; for instance, Nu Skin Enterprises, Inc. has a P/E ratio of 5.47 and an EV to EBITDA of 8.64, highlighting a more favorable valuation. Additionally, Grove Collaborative Holdings, Inc. is categorized as risky with an EV to EBITDA of -4.96, further emphasizing the challenges faced by Safety Shot, Inc. Without available return data, it is difficult to assess the company's performance against the S&P 500, but the overall financial metrics suggest that it is not positioned well in the market.